AzTrials
AzTrials

Intracranial AneurysmsPhase 4NCT01029938

Treatment of Cranial Internal Carotid Artery Aneurysm With Willis Covered Stent and Coil Embolization

A Phase 4 study testing Covered stent and Coil in people with Intracranial Aneurysms, run by Shanghai Jiao Tong University School of Medicine at 2 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Intracranial aneurysm treatment with coil embolization is associated with relatively low complete occlusion and high recanalization rates. The investigators evaluate whether Willis covered stent implantation yields angiographic and clinical results superior to those with coil embolization. Read more about this study

Who is it for?
Ages 10 to 85 years
Conditions the study is for
Intracranial Aneurysms
What is being tested?
Covered stent and Coil
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
85 participants
Where
2 sitesChina
Study dates
Apr 2005to Jun 2010
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 85 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Definite CICA aneurysm, either ruptured or unruptured, as demonstrated by arterial angiography;
  • Parent artery diameter of 3.0-5.0 mm;
  • Good tolerance of BOT; and
  • At least one control angiogram taken > 6 months after the initial treatment

Who cannot join

  • An extremely tortuous vessel proximal to the parent artery and/or lack of appropriate accessible routes, thereby rendering the patient unsuitable for endovascular treatment;
  • Parent artery diameter of < 3 mm or > 5.0 mm;
  • Inability of the patient to undergo general anesthesia or endovascular intervention; or
  • Expected patient survival of < 1 year because of other co-existing diseases. -

Trial locations and contacts

2 sites in 1 country.

Yong-Dong Li, MD., Ph.D. contact

0086-21-64844183

dr_liyongdong@sina.com.cn

Ming-Hua Li, MD.,Ph.D. contact

0086-21-64844183

liminhua@online.sh.cn

China2 sites, 2 recruiting
  • The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University

    Shanghai, Shanghai Municipality, 200233

    Recruiting
  • The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University

    Shanghai, Shanghai Municipality, 200233

    Yong-Dong Li, MD, Ph.D., 0086-21-64844183, dr_liyongdong@sina.com.cn

    Ming-Hua Li, MD, Ph.D., 0086-21-64844183, liminhua@online.sh.cn

    Recruiting

Other trials in China

About this study

Official title: Comparative Study of Covered Stent With Coil Embolization in the Treatment of Cranial Internal Carotid Artery Aneurysm: A Nonrandomized Prospective Trial

Intracranial aneurysm treatment with coil embolization is associated with relatively low complete occlusion and high recanalization rates. The investigators evaluate whether Willis covered stent implantation yields angiographic and clinical results superior to those with coil embolization.

Read the detailed description

Endovascular treatment of intracranial aneurysms with detachable coils has been widely used since the introduction of GDCs in 1991 and has been proven to be effective in preventing rebleeding after aneurysmal rupture. The clinical and angiographic results of endovascular coil occlusion of intracranial aneurysms are positive, with an initial and final overall complete occlusion rate of 35.9%-76.8% and 38.3%- 87.8%. In the mid- and long-term, however, aneurysm recanalization may occur in as many as one-third of cases.

The natural history of aneurysm recurrence after coil treatment is often benign, but bleeding from incompletely coiled aneurysms is a well-documented threat, moreover, the degree of aneurysm occlusion after treatment was strongly associated with risk of rerupture. Even if 100% occlusion of the aneurysms after the initial treatment was obtained on immediate postembolization angiography, there was still a relatively high recanalization rate (26.4%) on long-term follow-up angiography. In a recent study, we have confirmed that there was still aneurysm perfusion of the aneurysm sac in a complete occluded aneurysm no matter on initial or follow-up rotate digital angiography. In addition, some authors have demonstrated that endothelialization of the aneurysm orifice following placement of GDCs can occur; however, it appears to be the exception rather than the rule.

To overcome these disadvantages, the Willis covered stent, specially designed for intracranial vasculature, has been developed by our institution and the MicroPort Medical Company (Micro-Port, Shanghai, China). Our preliminary results demonstrated good flexibility and efficacy of the Willis covered stent in the treatment of cranial internal carotid artery aneurysms (CICA) in patients without an extremely tortuous ICA (Radiology 2009; 253:470-7), and also the covered stents have been proved to be more effective than re-coiling with regard to complete occlusion of recurrent aneurysms (J Neurol Neurosurg Psychiatry 2009;16:[Epub ahead of print]). Since 2005, we have performed a nonrandomized prospective trial of endovascular treatment CICA aneurysms with a covered stenting or coil embolization. So, we evaluate whether implantation of a primary Willis covered stent yielded angiographic and clinical results that superior to those with the currently recommended approach of coil embolization.

Being tested
Covered stent, Coil
Keywords
Intracranial aneurysms;, Covered stent;, Coil embolization
Medical subject headings
Intracranial Aneurysm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Covered stentProcedure or surgery

    Also called GDCs, covered stent

    Consecutive patients with CICA aneurysms were endovasculartreated with a Willis covered stent (group A) or coil embolization (group B)

  • CoilProcedure or surgery

    Also called GDCS, covered stent

    Consecutive patients with CICA aneurysms were endovasculartreated with a Willis covered stent (group A) or coil embolization (group B)

Study groups in NCT01029938
Study groupRoleWhat they receive
Covered stentActive comparatorThe Willis covered stent specifically designed for intracranial vasculature was developed by our institution and the MicroPort Medical Company (Shanghai, China), and coil embolization, which has been widely applied for nearly two decades, is currently the endovascular approach that is first recommended for intracranial aneurysm treatment.
Receives: Procedure: Covered stent; Procedure: Coil
CoilActive comparatorCoil embolization, which has been widely applied for nearly two decades, is currently the endovascular approach that is first recommended for intracranial aneurysm treatment.
Receives: Procedure: Covered stent; Procedure: Coil

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Willis covered stent indicate good flexibility and efficacy in cranial internal carotid artery (CICA) aneurysm treatment in patients without an extremely tortuous ICA

    Measured: 53 months after the study

Secondary outcomes (1)
  1. Willis covered stents are more effective than recoiling with respect to the complete occlusion of recurrent aneurysms

    Measured: 56 months after the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2009 (estimated)
  2. Study startApr 2005
  3. Primary completionSep 2008
  4. Study completionJun 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
85 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01029938
Sponsor's protocol ID
CASC2
Other IDs
SAPH002
Status last verified
Dec 2009
First submitted
8 Dec 2009
Last updated
23 Jul 2010
Results posted
No
Data monitoring committee
Yes

Publications

  • Li MH, Li YD, Tan HQ, Luo QY, Cheng YS. Treatment of distal internal carotid artery aneurysm with the willis covered stent: a prospective pilot study. Radiology. 2009 Nov;253(2):470-7. doi: 10.1148/radiol.2532090037. Epub 2009 Sep 29.

    PubMed 19789235
  • Li YD, Li MH, Gao BL, Fang C, Cheng YS, Wang W, Li WB, Zhao JG, Zhang PL, Wang J, Li M. Endovascular treatment of recurrent intracranial aneurysms with re-coiling or covered stents. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):74-9. doi: 10.1136/jnnp.2009.171967. Epub 2009 Aug 16.

    PubMed 19687026
  • Li MH, Leng B, Li YD, Tan HQ, Wang W, Song DL, Tian YL. Comparative study of covered stent with coil embolization in the treatment of cranial internal carotid artery aneurysm: a nonrandomized prospective trial. Eur Radiol. 2010 Nov;20(11):2732-9. doi: 10.1007/s00330-010-1854-z. Epub 2010 Aug 11.

    PubMed 20700595

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Covered stent and Coil in people with Intracranial Aneurysms, run by Shanghai Jiao Tong University School of Medicine at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yong-Dong Li, MD., Ph.D. (0086-21-64844183, dr_liyongdong@sina.com.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Willis covered stent indicate good flexibility and efficacy in cranial internal carotid artery (CICA) aneurysm treatment in patients without an extremely tortuous ICA (time frame: 53 months after the study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01029938, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in